EXEL has been one of the biggest failures in the history of biotech if you measure failure in terms of cumulative operating losses. Even the company’s original research focus in crop science failed to produce anything of consequence.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”